Antagonist
Monitors
Monitors
Julia Skellie · 144問 · 2年前Monitors
Monitors
144問 • 2年前Positioning
Positioning
Julia Skellie · 88問 · 2年前Positioning
Positioning
88問 • 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
Julia Skellie · 122問 · 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
122問 • 2年前AntiArrhythmics
AntiArrhythmics
Julia Skellie · 70問 · 2年前AntiArrhythmics
AntiArrhythmics
70問 • 2年前just dont forget:
just dont forget:
Julia Skellie · 8問 · 2年前just dont forget:
just dont forget:
8問 • 2年前Rspiratory
Rspiratory
Julia Skellie · 42問 · 2年前Rspiratory
Rspiratory
42問 • 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
Julia Skellie · 48問 · 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
48問 • 2年前Emergence
Emergence
Julia Skellie · 29問 · 2年前Emergence
Emergence
29問 • 2年前PACU
PACU
Julia Skellie · 14問 · 2年前PACU
PACU
14問 • 2年前Random
Random
Julia Skellie · 19問 · 2年前Random
Random
19問 • 2年前pharm exam 3
pharm exam 3
Julia Skellie · 42問 · 2年前pharm exam 3
pharm exam 3
42問 • 2年前Pharm Induction Agents
Pharm Induction Agents
Julia Skellie · 58問 · 2年前Pharm Induction Agents
Pharm Induction Agents
58問 • 2年前Laparoscopic Surgery
Laparoscopic Surgery
Julia Skellie · 39問 · 2年前Laparoscopic Surgery
Laparoscopic Surgery
39問 • 2年前Hematology Coagulation
Hematology Coagulation
Julia Skellie · 66問 · 2年前Hematology Coagulation
Hematology Coagulation
66問 • 2年前LIVER
LIVER
Julia Skellie · 84問 · 2年前LIVER
LIVER
84問 • 2年前ENT
ENT
Julia Skellie · 17問 · 2年前ENT
ENT
17問 • 2年前Opioids
Opioids
Julia Skellie · 18問 · 2年前Opioids
Opioids
18問 • 2年前MH
MH
Julia Skellie · 32問 · 2年前MH
MH
32問 • 2年前NeuroSurg
NeuroSurg
Julia Skellie · 20問 · 2年前NeuroSurg
NeuroSurg
20問 • 2年前Burns
Burns
Julia Skellie · 89問 · 2年前Burns
Burns
89問 • 2年前Regional
Regional
Julia Skellie · 11問 · 2年前Regional
Regional
11問 • 2年前問題一覧
1
phenoxybenzamine
2
phenoxybenzamine
3
30-70 mcg/kg
4
hyperkalemia
5
phentalomine
6
prazosin
7
yohimibine
8
prazosin
9
bladder relaxation, nasal congestion
10
less, longer
11
tamsulosin, prazosin, terazosin
12
increase of cAMP
13
decrease in IP3 and DAG
14
ACEI
15
metoprolol
16
decrease in renin, bronchoconstrition, hyperkalemia
17
propranolol
18
beta antagonist
19
tachycardia
20
decrease
21
hyperkalemia
22
nonselctive beta antagonist
23
decrease in cAMP
24
B1 = B2
25
B1 = B2 > a1
26
labetalol
27
Timolol
28
1-10mg
29
atenolol
30
atenolol
31
Esmolol
32
10-80mg
33
1-15 mg
34
most selective beta 1 antagonist
35
atenolol
36
orthostatic hypotension
37
4-hydroxy propranolol
38
Esmolol
39
Esmolol
40
labetalol
41
thyroid storm, htn due to laryngoscopy
42
pacemaker
43
B1 = B2
44
propranolol
45
propranolol
46
propranolol
47
decrease HR, decrease BP, increase airway resistance
48
Labetalol
49
0.1-0.5mg/kg
50
labetalol
51
9 min
52
ACE I
53
vasoconstriction
54
increase aldosterone secretion
55
Gq
56
peptidyl-depeptidase
57
ACE I
58
false
59
beta antagonists
60
poor patient compliance
61
persistent cough, prolonged hypotension, angioedema, loss of taste
62
decreases SVR, onset 15 min, angioedema
63
renal artery stenosis pregnancy
64
lisinopril
65
false
66
150/90
67
140/90
68
140/90
69
thiazide diuretic
70
heart failure, MI, high CVD risk
71
thiazide diuretic, BB, ACEI, ARB, aldosterone antagonist
72
BB, ACEI, aldosterone antagonist
73
thiazide diuretic, BB, ACEI, CCB
74
DBP > 120, evidence of progressive end organ damage
75
DBP > 120, evidence of end organ failure
76
decrease DBP to 100-105 within 24 hours, clonidine
77
decrease DBP to 100-105 asap, nitroprusside
78
nitroprusside, nitroglycerin, labetalol, fenoldapam
79
Nadolol, penbutolol, pindolol, propranolol, timolol
80
acebutolol, atenolol, bisoprolol, esmolol, metoprolol
81
carteolol, carvedilol, bucindolol, labetalol
82
betaxolol, caliprolol, nebivolol
83
a1 = a2
84
a1>>>>a2
85
a1 > a2
86
decrease PVR, decrease BP, miosis
87
phentalomine
88
phenoxybenzamine
89
2.5-5.0 mg
90
30-70 mcg/kg
91
less likely to cause tachycardia, dilates both arterioles and veins, used pre-op with patients with pheochromocytoma, a1 >>> a2
92
competive bond, peripheral vasodilation, a1 = a2, increase CO
93
onset 1 hour, use caution with repeated doses, a1 > a2, decrease in SVR
94
alpha 2 selective blocker, treats orthostatic hypotension, treats impotence
95
treats BPH, adverse effect: orthostatic hypotension, elimination half time varies
96
influences inotropy and chronotropy, competitive and reversible, chronic use associated with uppregulation, can provoke bronchospams, vasoconstriction of skeletal muscle
97
pre-existing AV heart block, cardiac failure, DM (without monitoring), hypovolemia, reactive airway disease
98
ACEI
99
ACEI
100
prevent conversion of angiotensin I to II